Related Experiment Video
Updated: Nov 2, 2025

Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung
Published on: January 22, 2021
Anti-biofilm activity of bacteriophages and lysins in chronic rhinosinusitis
Abstract:
Chronic rhinosinusitis (CRS) is an otolaryngological disease with a recalcitrant nature, predominantly due to antibiotic resistant bacteria and the biofilm formation. The intracellular residency of Staphylococcus aureus bacteria was observed in CRS. The overall prevalence of CRS is estimated between 5-15% in the human population, and biofilms were formed in sinuses in 40-80% of cases. The bacterial species S. aureus and Pseudomonas aeruginosa are known to form difficult to treat biofilms in CRS. Bacteriophages (phages) or lysins can be alternatives to antibiotics in the biofilm treatment. The application of a P. aeruginosa phage cocktail ex vivo decreased biofilm biomass of bacterial isolates from the sinuses of CRS patients by a median of 70%. Further, animal studies performed on a sheep sinusitis model demonstrated significant reduction in S. aureus and P. aeruginosa biofilm biomass by phage cocktails while maintaining safe prolonged topical application (up to 20 days). Staphylococcal lysin P128 used at a concentration of ≥12.5 µg/ml in vitro against the biofilm of methicillin sensitive S. aureus (MSSA) and methicillin resistant S. aureus (MRSA) isolates from the sinuses of CRS patients demonstrated a significant reduction of the biofilm (up to 95.5%). Staphylococcal lysin CHAP(k) applied in vivo in mice nasal infection caused a significant 2 log reduction of S. aureus suggesting its potential use against bacteria in nasal mucosa. Furthermore, a beneficial effect of phage therapy in the treatment of chronic sinusitis in humans was observed. Here, we summarize the recent, quite scarce data regarding phage application in chronic rhinosinusitis and look further into this phenomenon. Keywords: bacteriophages; biofilm; chronic rhinosinusitis; lysins; phage therapy.
Insights
Bacteriophages and lysins show promise as alternatives to antibiotics for treating chronic rhinosinusitis (CRS). These agents effectively reduced bacterial biofilms in lab and animal studies, with some human data suggesting therapeutic benefits.
Area of Science:
- Otolaryngology
- Microbiology
- Biotechnology
Background:
- Chronic rhinosinusitis (CRS) is a common, difficult-to-treat condition often linked to antibiotic-resistant bacteria and biofilm formation.
- Staphylococcus aureus and Pseudomonas aeruginosa are key bacterial species implicated in CRS biofilms.
- Bacterial intracellular residency is a feature of CRS, complicating antibiotic treatment.
Purpose of the Study:
- To review current data on bacteriophage and lysin applications for chronic rhinosinusitis.
- To explore the potential of phage therapy and lysins as alternatives to conventional antibiotics for CRS treatment.
Main Methods:
- Review of existing literature on phage and lysin efficacy against CRS-related bacteria.
- Analysis of ex vivo and in vivo studies using phage cocktails and lysins on bacterial biofilms.
- Examination of animal models and limited human data on phage therapy for sinusitis.
Main Results:
- Phage cocktails significantly reduced Pseudomonas aeruginosa and Staphylococcus aureus biofilm biomass in ex vivo and animal models.
- Staphylococcal lysins P128 and CHAP(k) demonstrated substantial in vitro and in vivo reductions of S. aureus biofilms.
- Positive outcomes in human cases suggest the therapeutic potential of phage therapy in CRS.
Conclusions:
- Bacteriophages and lysins represent promising alternatives to antibiotics for combating bacterial biofilms in chronic rhinosinusitis.
- Further research into phage therapy and lysin applications is warranted for effective CRS treatment strategies.
Related Concept Videos
Chronic Pharyngitis
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...
Lytic Cycle of Bacteriophages
Biofilms
Gene Regulation in Microbial Communities: Quorum Sensing
Viral Replication: Lysogenic Cycle

